Santen Pharmaceutical Co., Ltd.
SNPHY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $55 | $5,878 | $8,791 | $8,693 |
| Dep. & Amort. | $32 | $4,497 | $4,399 | $4,507 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$57 | -$5,189 | -$18,661 | $14,652 |
| Other Non-Cash | $11 | -$5,133 | $24,361 | -$14,122 |
| Operating Cash Flow | $40 | $53 | $18,890 | $13,730 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$50 | -$1,856 | -$927 | -$3,056 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$1 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $1,841 | -$49 | $287 |
| Investing Cash Flow | -$51 | -$15 | -$976 | -$2,769 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$881 | -$3,154 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$136 | -$8,050 | $0 | -$13,513 |
| Dividends Paid | -$0 | -$6,408 | -$67 | -$5,876 |
| Other Fin. Act. | -$6 | $15,233 | $2,360 | -$828 |
| Financing Cash Flow | -$142 | -$106 | -$861 | -$20,217 |
| Forex Effect | -$3 | $32 | -$1,908 | $2,665 |
| Net Chg. in Cash | -$155 | -$36 | $92,997 | $0 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $586 | $622 | $0 | $0 |
| End Cash | $430 | $586 | $92,997 | $0 |
| Free Cash Flow | $30 | $41 | $17,963 | $10,674 |